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microparticles, and the amounts of EMPs from plasma were increased. In ECs, along
with TF upregulation, miR-19b release and expression were increased stimulated by
TNF-a. Luciferase reporter assays demonstrated that miR-19b bind to TF mRNA.
Overexpression of miR-19b inhibited TF expression and procoagulant activity.
Conclusions: In UA patients, the increasement of miR-19b wrapped in EMPs for
endothelial dysfunction may partialy contributed to the circulating miR-19b elevation.
MiR-19b may play an anti-thrombotic role by inhibiting the expression of TF in ECs.
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Objectives: Endothelial progenitor cells (EPCs) contribute to angiogenesis and acidic
ﬁbroblast growth factor (FGF1) gene transfer enhances EPC function. The Forkhead box
O transcription factors (FOXOs) play an important role in the regulation of various
cellular processes and EPCs mainly express FOXO3a. Here, we aimed to determine
whether FGF1 promotes EPC function through Akt/FOXO3a signaling pathway.
Methods: EPCs were cultured from human peripheral blood and transduced with
adenoviral vectors expressing a non-phosphorylatable, constitutively active mutant of
FOXO3a (Ad-TM-FOXO3a) and the GFP transgene (Ad-GFP) used as control. The
Ad-GFP group treated with FGF1 showed the functional improvement including cell
survival, proliferation, migration and tube formation, whereas the above promoting
effects were reversed after adding Akt inhibitor.
Results: The Ad-TM-FOXO3a group showed the reduced functionality compared with
the control and failed to make the functional recovery after FGF1 treatment. Western
blotting revealed that FGF1 made EPC functional enhancement through upregulating
the phosphorylation of Akt and FOXO3a which could be suppressed by Akt inhibitor.
Conversely, FGF1 failed to rescue EPCs transduced with Ad-TM-FOXO3a from
dys-function because the mutant FOXO3a were not phosphorylated by Akt.
Conclusions: FGF1 promoting EPC function is mediated through Akt/FOXO3a
signaling pathway. The molecular mechanism of EPC functional improvement we
initially explored may provide new ideas for the future to enhance the EPC angiogenic
effect and optimize the EPC transplantation therapy.
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Objectives: Atypical coronary artery disease (ACAD) is characterized by atypical
angina pectoris or silent myocardial ischemia. However, conventional diagnostic
techniques are insufﬁcient to identify this subtype of coronary atherosclerotic pa-
thology, and speciﬁc and sensitive markers for diagnosing ACAD are still currently
lacking. The aim of the present study is to identify a novel serum miRNA expression
proﬁle of ACAD patients and evaluate its clinical diagnostic value.
Methods: We enrolled 122 patients who were diagnosed with ACAD and 44 age-
matched controls in this study. We examined the levels of a subset of serum miRNAs
in both ACAD and control samples. In addition, we sought to predict the potential
target genes of the altered miRNAs using bioinformatics methods.
Results: By using TaqMan low density array technology followed by conﬁrmation with
quantitative real-time PCR (qRT-PCR), we identiﬁed four miRNAs including miR-
487a, miR-502, miR-208 and miR-215 that were signiﬁcantly increased, and one
miRNA, miR-29b which was signiﬁcantly decreased in ACAD patients compared with
normal subjects (P< 0.05). The area under the ROC curve (AUC) for the ﬁve miRNAs
ranged from 0.670 to 0.876 (P< 0.05), and their panel (0.885) was signiﬁcantly higher
than that of hsTnI (0.627). In addition, target gene prediction showed that these ﬁve
altered miRNAs are involved in affecting various aspects of cardiac or vascular
remodeling, especially in the pathway involving inﬂammation and ﬁbrosis.
Conclusions: Our ﬁndings indicate that the ﬁve altered serum miRNAs could be
novel non-invasive biomarkers for ACAD and may also represent potential thera-
peutic targets for atherosclerosis and myocardial ischemia.
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Objectives: To explor the effects of trimetazidine on myocardial structure damaged
by pyran adriamycin and to clarify the protection and mechanism of trimetazidine on
damaged myocardial structure induced by pyran adriamycin.C64 JACC Vol 64/16/Suppl C j OctobMethods: 36 Wistar rats were randomly divided into control group, model group and
treatment group. Rats in model group and treatment group were injected pyran
doxorubicin 2.5mg/kg (concentration 2mg/ml) by the vena caudal once a week.
Control group were injected equivalent normal saline in a coordinative control for 6
weeks. Rats in treatment group were intragastric infuse trimetazidine 5.4mg/kg/d one
day before making the model. Control group, model group were injected equivalent
normal saline in a coordinative control for 8 weeks. At the end of the experiment,
index of heart mass of rats and myocardial enzymes of serum were measured. Systolic
and diastolic function were detected with echocardiography. The myocardium tissue
were detected by light microscope and electron microscope.
Results: Compared with model group, the level of myoglobin, troponin and alanine
transaminase (ALT) in treatment groupwere decreased (P<0.05). Index of heart mass in
treatment group is lower than that in model group and nearly the level of control group.
Compared with control group, EF and FS in model group decreased (P<0.01) and
LVIDD, LVIDS in creased (P<0.05). EF and FS in Group C is larger than that in Group
B (P<0.05), LVIDS, LVIDD in treatment group is lower than model group (P<0.05).
Under the lightmicroscope observation, inmodel groupmyocardial arranged disorderly,
severely damaged structure, multiple visibl emyocardial, myoﬁlament dissolved, frac-
ture, while in treatment group myocardial arranged in order, structure was nearly inte-
grated, partial dissolution, fracture. Under the electronmicroscope observation, inmodel
group myocardial muscle bundle dissolved fractured, disappeared, mitochondria
decreased, cytoplasmic matrix cavitation, while in treatment group, arrangement of
cardio myocytes sarcomeres in tow, local myoﬁlaments reduced slightly, surrounding
mitochondria were oval and arranged in parallel between the muscle bundles.
Conclusions: Trimetazidine can protect the damaged cardiomyocytes and improve the
cardiac function caused by pyran adriamycin, and its mechanism may be related to
decrease the injury of mitochondria and myocytes
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Objectives: Recent evidence indicates that platelet indices and white blood cell
(WBC) are associated with the prognosis of patients with acute aortic dissection (AD).
However, there have been no systematic investigations on the utility of baseline mean
platelet volume (MPV) to platelet count (PC) ratio (MPV/PC ratio) and WBC for
predicting the survival of acute AD. The present study was designed to examine
whether the MPV/PC ratio and WBC could predict mortality in acute AD
Methods: Baseline clinical details and hematologic parameters were obtained pro-
spectively in 272 acute AD patients consecutively admitted to a single medical center.
The levels of MPV, PC and WBC were determined after their initial admission and
evaluated, in concert with follow-up patient survival data, to determine if the MPV/PC
ratio and WBC could predict mortality. Between initial measurement and follow-up
(medium time: 570 (11-1222.5) days)
Results: Increased levels of plasma MPV/PC ratio (6.3513 (4.6439-8.8730) versus
5.3939 (4.068-6.7415), P<0.001) and WBC (11.90 (8.85-16.03) vs 9.91 (7.46-13.05),
P<0.001)were found indead patients comparedwith those survivedduring the follow-up.
Multivariable analysis showed that MPV/PC ratio (P¼0.014, OR¼1.179, 95% CI: 1.034
to 1.344) and WBC (P¼0.011, OR¼1.106, 95% CI: 1.024 to 1.195) was an independent
predictor for all-cause mortality during follow-up, respectively. The areas under receiver
operating characteristic (ROC) curves of MPV/PC ratio and WBC were 0.618 (95% CI:
0.542 to 0.694) and 0.625 (95% CI: 0.553 to 0.698) for predicting follow-up mortality,
with a sensitivity of 39.8%, speciﬁcity of 88.1%, cut-off valueof 7.55197102fL/ (109/L)
and a sensitivity of 52.7%, speciﬁcity of 68.9%, cut-off value of 11.53109/L, respec-
tively, While the areas under ROC curves of combination WBC and MPV/PC ratio was
0.674 (95%CI: 0.603 to 0.745) with a sensitivity of 39.8%, speciﬁcity of 88.1%. Kaplan-
Meier analysis and log-rank test revealed signiﬁcant survival differences between patients
with a MPV/PC ratio<7.55197102fL/ (109/L) and a MPV/PC ratio7.55197102fL/
(109/L) (P<0.001) and with a WBC <11.53109/L and a WBC 11.53109/L
(P<0.001). Subgroup analysis showed MPV/PC ratio had prognostic value for mortality
in patients with type A (P<0.001), surgery (P¼ 0.007) and only medication treatment
(P<0.001), no predictive value were found in patients with type B (P¼0.410) and
endovascular treatment (P¼ 0.822) patients, while prognostic value ofWBC formortality
was found in patients with type A (P¼0.004) and only medication treatment (P¼0.004).
Conclusions: the elevated MPV/PC ratio and WBC were important risk factors and
independently associated with mortality of patients with acute AD. These patients may
beneﬁt more from surgical intervention and endovascular treatment.
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